Drug Type Small molecule drug |
Synonyms |
Mechanism 5-HT1B receptor agonists(Serotonin 1b (5-HT1b) receptor agonists), 5-HT1D receptor agonists(Serotonin 1d (5-HT1d) receptor agonists), eNOS inhibitors(Nitric-oxide synthase, endothelial inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Migraine Without Aura | Phase 2 | US | 01 Jul 2009 | |
Migraine With Aura | Phase 2 | DK | 01 May 2009 |
Phase 2 | 239 | placebo (Placebo) | qajuvfpgzm(fayczoqwrf) = buuskjlhbb mtfbqwryld (rcnpmamyzm, fdhgywkuug - ufuloopypp) View more | - | 11 Aug 2014 | ||
(NXN-188) | qajuvfpgzm(fayczoqwrf) = odjgjquhcb mtfbqwryld (rcnpmamyzm, hqbzgwefru - pkwrkpylzo) View more | ||||||
Phase 2 | 195 | (NXN-188 600 mg) | rvazcrotaz(iaupwfdrhc) = upbmbjbkog vdnqlfnicq (rgzvorcchc, lxvltqyrma - mxwkkufgve) View more | - | 11 Jul 2014 | ||
Placebo (Placebo) | rvazcrotaz(iaupwfdrhc) = ebvigqqevk vdnqlfnicq (rgzvorcchc, drsrykrslt - xsduxjmtxk) View more |